Latest News
News
Renaissance of interest in medicines modulating ECS: Rising to the challenge
Steve McConchie, CEO at Aptus Clinical shares his analysis on cannabinoid medicines, with Andy Yates of Artelo Biosciences, in Pharmafile. The body’s endocannabinoid system (ECS) consists of receptors and chemical messengers located in the central and peripheral nervous system, forming…
Read more >Aptus Clinical selected as clinical CRO by Artelo Biosciences
Aptus Clinical has been appointed full service clinical CRO partner by Artelo Biosciences Inc. (through their fully owned UK subsidiary, Trinity R&D Ltd.) to deliver the upcoming Phase 1B/2A trial of their synthetic cannabinoid, ART27.13. This latest agreement builds on…
Read more >Aptus Clinical is a very supportive workplace, keen on developing people
We say goodbye to Anitah who has now come to the end of her one year work placement with us. Here is what she had to say: As we draw near to my final day here at Aptus I…
Read more >Aptus Clinical launches a full Clinical Data Management Service, thanks to iMATCH
Innovate UK funding spurs growth in iMATCH companies As a result of their involvement in the iMATCH Project, Aptus Clinical are now able to offer a full Clinical Data Management service, offering a wide range of services from eCRF Design,…
Read more >North takes on South in UK’s life science industry – Financial Times
Aptus Clinical is proud to be mentioned in this article from todays FT –https://www.ft.com/content/e63b6006-9cdb-11e9-b8ce-8b459ed04726 When Ruth Roberts heard that AstraZeneca, where she had worked for a decade, was leaving its home at Alderley Park in Cheshire for a new headquarters…
Read more >Aptus Clinical signs consulting contract with ValiRx plc
ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, is pleased to announce that the Company’s clinical team has signed an agreement to work with Aptus Clinical Ltd (“Aptus”), the UK based, clinical Contract Research Organisation (“CRO”), to effectuate a…
Read more >NHS patients to get faster access to pioneering treatments
New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines, diagnostic tools and digital services through the clinical development and regulatory approval process faster. The AAC was set up in 2018 to speed up the time it takes for…
Read more >How Viedoc helps us optimise data capture and reduce our study lead times
Paul Blaney, Digital Health Lead at Aptus Clinical, explains why, having evaluated six EDC systems, they opted for Viedoc. https://www.viedoc.com/blog/functionality-and-usability-reduce-lead-times-the-reason-cro-aptus-clinical-chose-viedoc/
Read more >Our growth story
Since its inception in 2014, specialist clinical Contract Research Organisation, Aptus Clinical has grown from strength to strength. Having won BioNow’s Start-up of the year in 2016 and been a shortlisted finalist for OBN’s Specialist CRO of the Year in…
Read more >Why are we based at Alderley Park?
Alderley Park has been the home of scientific innovation for decades, particularly for oncology research. Here a number of contributors, including our CEO Steve McConchie, explain the advantages of building a business here.
Read more >